TruSpine Technologies #TSP – Final Results & Update re Suspension October 14, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the spinal (vertebral) stabilisation market, reports its full year results for the year ended 29 March 2025. Suspension Following publication of these results, the Company’s shares is anticipated to be restored to trading on the AQSE Growth Market with effect from 8:00a.m. on 15 October 2025 The Company continues to be in a pre-revenue development phase and remains loss-making at this stage of its…

TruSpine #TSP August 2023 – CEO Laurence Strauss talks to Alan Green August 24, 2023 – Posted in: Blog, TruSpine Plc (TSP)

Alan Green talks to Truspine #TSP CEO Laurence Strauss about the developments year to date, and the Company’s recent 510k submission to the US FDA for approval of the Cervi-LOK spinal stabilisation system. Laurence outlines his plans for a US trip to meet with the IP lawyers and the equipment distributors before we discuss the timeframe for future submissions for the other portfolio products GRASP Laminoplasty and Faci-LOK. We then look at the Company funding…

Truspine Technologies #TSP – Further re: FDA Update July 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, further to the announcement on 1 August 2022, the Company confirms that the FDA 510k submission for Cervi-LOK has been made to the FDA. The FDA’s decision to provide clearance normally takes up to 90 days, following which the Company will be able to commence marketing and sales of Cervi-LOK in the US, if clearance is received from the…

TruSpine #TSP transition – CEO Laurence Strauss talks to Alan Green May 23, 2023 – Posted in: Blog, TruSpine Plc (TSP), Vela Technologies Plc (VELA)

Aquis Exchange listed Truspine Technologies #TSP is both owner and developer of three uniquely disruptive technologies to revolutionise the spinal stabilisation market. These pioneering spinal devices, namely Cervi-LOK™ (for the cervical and upper thoracic spine), GRASP Laminoplasty (a treatment for decompression of the spinal cord) & Faci-LOK™ (for the lumbar and lower thoracic spine) are at various stages of development. Alan Green is joined today by newly appointed CEO Laurence Strauss to discuss his appointment…

#TSP.AQSE TRUSPINE TECHNOLOGIES PLC – NOTICE OF GENERAL MEETING May 5, 2023 – Posted in: Blog, TruSpine Plc (TSP), Uncategorized

The Company announced on 26 April 2023 that it had received a valid request under section 303 of the Companies Act 2006 to convene a general meeting to consider resolutions to remove Norman Lott, Nikunj Patel, Annabel Schild and Laurence Strauss as directors of the Company and appoint Todd Michael Cramer, Peter Houghton and Anthony Swoboda as directors of the Company, as well as to re-convene the adjourned 2022 Annual General Meeting as soon as…

TruSpine #TSP – Director Loan, Related Party Transaction and Update April 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £100,000 loan agreement with Annabel Schild, Non-Executive Director of the Company (the “Loan Agreement”). Loan Agreement Pursuant to the Loan Agreement, the Company has received £100,000 (“Funding Loan”) which will be utilised for general working capital purposes. The Funding Loan is unsecured and bears an interest rate of 6 per cent. per annum starting…

VELA TECHNOLOGIES #VELA INVESTEE COMPANY #TSP TruSpine Technologies plc – Company Update & Board Changes April 5, 2023 – Posted in: Vela Technologies Plc (VELA)

5th April, 2023 TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless” spinal (vertebral) stabilisation systems, provides an update on its business collaborators and FDA application process, changes to the Company’s board composition and the appointment of new public and investor relation advisers. Company Update The Company has terminated a consultancy agreement with J Lees S Consultants LLC (“JLSC”) through which, inter alia, the services of Frank Boehm…

Truspine #TSP – Company Update and Board Changes – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless” spinal (vertebral) stabilisation systems, provides an update on its business collaborators and FDA application process, changes to the Company’s board composition and the appointment of new public and investor relation advisers. Company Update The Company has terminated a consultancy agreement with J Lees S Consultants LLC (“JLSC”) through which, inter alia, the services of Frank Boehm were provided.…

TruSpine Technologies #TSP – Final Results & Update re Suspension October 14, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine #TSP August 2023 – CEO Laurence Strauss talks to Alan Green August 24, 2023 – Posted in: Blog, TruSpine Plc (TSP)

Truspine Technologies #TSP – Further re: FDA Update July 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine #TSP transition – CEO Laurence Strauss talks to Alan Green May 23, 2023 – Posted in: Blog, TruSpine Plc (TSP), Vela Technologies Plc (VELA)

#TSP.AQSE TRUSPINE TECHNOLOGIES PLC – NOTICE OF GENERAL MEETING May 5, 2023 – Posted in: Blog, TruSpine Plc (TSP), Uncategorized

TruSpine #TSP – Director Loan, Related Party Transaction and Update April 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

VELA TECHNOLOGIES #VELA INVESTEE COMPANY #TSP TruSpine Technologies plc – Company Update & Board Changes April 5, 2023 – Posted in: Vela Technologies Plc (VELA)

Truspine #TSP – Company Update and Board Changes – Posted in: Blog, TruSpine Plc (TSP)

Address

Contact

Social

LEGAL